… in our final meta-analysis. The average prevalence of BRAF mutation was 9.6% in colorectal
cancer, and 47.8% in melanoma reports. We found that BRAF mutation increases the risk of …

… The overall prevalence of the BRAF mutation was 45%. The risk ratios in BRAF mutation-positive …
Thus, in this meta-analysis, the BRAF mutation in PTC was significantly associated with …

… BRAF mutations occur in some melanomas. We hypothesized that BRAF mutation rates …
In the present study, we investigated the association between the frequency of BRAF mutation …

… Our analysis showed that no association was observed between BRAF mutations and … Our
meta-analysis indicated that BRAF mutations were more common in ADCs than those in other …

… In the current analysis, BRAF mutation was associated with poor differentiation and
locally advanced (T4) tumours. This distinction in features could be important in tailoring …

… meta-analysis (1) were published as a full text in English. (2) the number of patients with
BRAF mutations … with the association between BRAF and demographic or clinicopathologic …

… , meta-analysis of the literature shows BRAF V600E mutation correlates with poor prognostic
features of PTC. Most studies, however, use disparate methods of BRAF mutation detection, …

… Firstly, our meta-analysis is mainly based on retrospective … , our meta-analysis provides
evidence that BRAF mutation has a … This mutation can be used as a prognostic factor in glioma …

… the HRs of the BRAF mutation for recurrence. In conclusion, the BRAF mutation does not
increase … should be considered when interpreting the impact of a BRAF mutation on recurrence. …

… Mutational data were also extracted and the different methods used to … BRAF mutation
were recorded. Patients were classified as BRAF mutation-positive (BRAF-mut) if a mutation was …